Mexico patient engagement solutions Market Analysis Sample Report

Mexico Patient
Engagement
Solutions Market
Analysis
A sample report on
www.insights10.com
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2023 – 2030F)

This report presents a strategic analysis of the Mexico Patient
Engagement Solutions Market and a forecast for its development in
the medium and long term. It provides a comprehensive overview of the
market value, dynamics, segmentation, main players, growth and demand
drivers, challenges & future outlook, etc. This is one of the most
comprehensive reports about the Mexico Patient Engagement Solutions
Market , and offers unmatched value, accuracy, and expert insights

3
A Sample Report on Mexico Patient Engagement Solutions Market Analysis I Confidential
Report Scope
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2022
Forecast Period 2023-2030
Report Coverage
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape,
Reimbursement Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Research Approach Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology

4
Table of Content
CONTENT PG. NO.
1. Patient Engagement Solutions Overview 12-25
1.1. Overview
1.2. Mexico Overview
1.3. Economic Overview: Mexico
1.4. Patient Engagement Solutions market in Mexico
1.5. Healthcare Services Market in Mexico
1.6. Healthcare Scenario in Mexico
1.7. Health Insurance Coverage: Mexico
1.8. Budget of the Government for Public Insurance
1.9. Mergers and Acquisitions
2. Market Size and Forecasting 26-33
2.1 Market size and forecasts (Excel and Methodology)

5
Table of Content
CONTENT PG. NO.
2.2. Market Segmentation
2.2.1. Component
2.2.2. Therapeutic area
2.2.3. Functionality
2.2.4. Delivery mode
3. Market Dynamics 34-38
3.1. Market Growth Drivers
3.1.1. Mexico Patient Engagement Solutions Market Driver 1
3.2. Market Restraints
3.2.1. Mexico Patient Engagement Solutions Market Restraint 1

6
Table of Content
CONTENT PG. NO.
4. Competitive Landscape 39-49
4.1. Major Market Share
4.2. Key Company Profile
4.2.1. Epic Systems corporation
4.2.1.1. Overview
4.2.1.2. Product Applications & Services
4.2.1.3. Recent Developments
4.2.1.4. Partnerships Ecosystem
4.2.1.5. Financials (Based on Availability)

7
Table of Content
CONTENT PG. NO.
4.2.2. AdvancedMD ( Global payments Inc.)
4.2.2.2. Overview
4.2.3. Allscripts Healthcare
4.2.3.1. Overview

8
Table of Content
CONTENT PG. NO.
4.2.4. Athenahealth
4.2.4.2. Overview
4.2.5. Cerner Corporation
4.2.5.1. Overview

9
Table of Content
CONTENT PG. NO.
4.2.6. EMMI Solutions
4.2.6.1. Overview
4.2.7. GetWellNetwork
4.2.7.1. Overview

10
Table of Content
CONTENT PG. NO.
4.2.8. Lincor Solutions Limited
4.2.8.1. Overview
4.2.9. McKesson corporation
4.2.9.1. Overview

11
Table of Content
CONTENT PG. NO.
4.2.10. Medecision Inc. ( Health care service corporation )
4.2.10.2. Overview
5. Reimbursement Scenario 50-57
5.1. Reimbursement Regulation
5.2. Reimbursement Process for Nutritional Supplements
6. Methodology & Scope 58-63

Mexico Patient Engagement Solutions Market Analysis
1. Patient Engagement Solutions Market Overview

13
1.1 Statistics at a Glance: Patient Engagement Solutions in the world
Prevalence of Patient Engagement Solutions ▪ Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪ In this section you will get an
understanding of the topic, which includes
the prevalence of patient engagement
solutions, CAGR and revenue , new
technology, and other details related to the
topic
▪ In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪ Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
18.1%
Is the CAGR at which
patient portal market a
component of patient
engagement solutions
is predicted to grow
$70 Bn
Was mHeath apps market
size in the year 2022
Illustrative
3.2 Mn
Medical IOT devices were
installed by healthcare
organizations globally in
2021
Software
Component had the
highest market share in
patient engagement
solutions market in 2022
13.55%
Is the CAGR by which patient
engagement solutions market
is expected to grow till
forecast of 2029
$17.3 Bn
Was the Patient
Engagement Solutions
market size in the year
2022

14
1.1 Statistics at a Glance: Patient Engagement Solutions in the World
(continued)
North America
~ Market Size of
$XX Bn
Europe
~Revenue to reach
$7.6 Bn by 2027
Asia
-Fastest CAGR
Africa
~Market Size of
$0.6Bn
Mexico Market
~$XX Mn Market
Illustrative

15
1.2 Mexico Overview
129.9 Mn
Is the population of
Mexico, in 2022
29.3
Is the median age
in Mexico, in 2022
1400 Bn
Is the Gross
Domestic Product
(GDP) in mexico in
2022
$538.5
Per capita was the
amount of national
health expenditures in
2022
▪ Please be aware that this sample report is
report
understanding of the demographics of the
country/region, which includes the
population, GDP, healthcare expenditure
and other details related to the topic
interest
Illustrative

16
1.3 Economic Overview: Mexico
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
Population of Mexico, (2020-2030)
XX
XX
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
GDP of Mexico, (2020-2030)
Population Split (2023)
55-64
0-14
15-24
25-54
65+
Male
48.87
Female
51.13
By Age Group
By Gender
▪ In this section you will get an understanding of the demographics
of the country/region, which includes the population, GDP,
healthcare expenditure and other details related to the topic
▪ In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative

17
1.4 Statistics at a Glance: Patient Engagement Solutions in Mexico
Prevalence of Patient Engagement Solutions
▪ Please be aware that this sample report
is intended to provide you with a brief
analysis that will be presented in the
final report
understanding of the topic, which
includes the prevalence of patient
engagement solutions in Mexico, new
technology, and other details related to
the topic in Mexico
information that you are seeking, you
will need to purchase the final report
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
3000 plus
Private hospitals in
Mexico use patient
engagement
solutions.
$ 266.07 Mn
Revenue from
teleconsultations was
generated in Mexico in 2021.
311.56 k
Total number of physicians in
Mexico in 2022
$ 82 Bn
Is the total healthcare
spending in Mexico in
year 2022.
On premise
Mode is the main
preferred mode of
electronic health records
by hospitals in Mexico.
2.53 Mn
Patients used telemedicine in
2021 in Mexico.
Illustrative

18
1.5 Healthcare Services Market in Mexico
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Mexico Healthcare Services Market Forecast, 2022-2030 (in $Mn)
▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be
presented in the final report
▪ In this section you will get an understanding of the overall Healthcare Services market in Mexico, which includes the market size, current
trends and other details related to the topic
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or
Illustrative

19
1.6 Healthcare Scenario in Mexico
Patient Engagement Solutions Treatment Process: The process of developing a cancer drug is complex and involves many stages, from
preclinical research to clinical trials to regulatory approval. Here is a simplified diagram of the cancer drug development process:
o Preclinical Research: Researchers identify potential drug candidates and test them in the lab
o Phase 1 Clinical Trials: Small studies are conducted to test the safety and dosage of the drug in humans
o Phase 2 Clinical Trials: Larger studies are conducted to test the effectiveness of the drug in treating cancer
o Phase 3 Clinical Trials: Even larger studies are conducted to compare the new drug to standard treatments and evaluate its safety and
effectiveness
o Regulatory Approval: The drug is reviewed by regulatory agencies such as the FDA and approved for use in the US market
Fast Track
▪ Fast track is a process designed to facilitate the development, and expedite the review of drugs to treat
serious conditions and fill an unmet medical need
Breakthrough
Therapy
▪ A process designed to expedite the development and review of drugs which may demonstrate substantial
improvement over available therapy
Accelerated
Approval
▪ These regulations allowed drugs for serious conditions that filled an unmet medical need to be approved
based on a surrogate endpoint
Priority Review ▪ A Priority Review designation means FDA’s goal is to take action on an application within 6 months
FDA has developed several approaches to making drugs available as quickly as possible, while still ensuring their safety and
effectiveness. Here are four of these approaches:
Illustrative

20
1.6 Healthcare Scenario in Mexico: Patient Journey
Presentation Diagnosis Treatment Follow up
A suspected diagnosis is
usually made, based on
physical examination and
detailed patient and family
history
Prenatal screening/
Neonatal screening
Initial Diagnosis
Complete blood count
(evaluate number &
quality of RBCs, Hb &
WBCs)
Imaging (confirm bone
related changes or
respiratory problems)
Bacterial cultures of
blood, sputum, urine,
stool (detect any
infection)
Genetic testing (detect
the type of SCD)
Confirmatory Diagnosis
Prevention and management of
crisis:
• For VOC and Splenic
Sequestration: HU, Endari,
Adakveo, Oxbryta
• For infections: Antibiotics,
Vaccines
Prevention and management of
complications:
• Stroke: Chronic transfusions, HU
• Long term follow-up is required for
patients with SCD
• Annual assessment: CBC and
reticulocyte count, iron status, liver
and renal function tests, urinalysis,
LDH, vitamin D level and
neurocognitive assessment
• ESOD (End Stage Organ Damage)
evaluation starting from age 7
• Yearly Transcranial Doppler test to
determine risk of stroke
Stakeholders
PCP, paediatrician,
neonatologist,
haematologist and genetic
counsellor
PCP, pediatrician, medical geneticist,
hematologist, gynecologist and pathologist
PCP, pediatrician, medical geneticist,
cardiologist, hematologist,
endocrinologist, psychologist and
psychiatrist
PCP, pediatrician, neonatologist,
endocrinologist, cardiologist,
hematologist, orthopedist, psychologist
and psychiatrist
Depending on the organ complications,
the treatment involves different
specialists at different times
Illustrative

21
1.7 Health Insurance Coverage: Mexico
1.0
18.9
18.4
35.7
2.5
3.5
10.2
54.3
66.0
91.7
8.3
VA and CHAMPVA
Medicaid
Medicare
Any public plan
TRICARE
Marketplace
Direct-purchase
Employment-based
Any private plan
With health insurance
Uninsured
▪ In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire
calendar year
▪ More people had private health insurance (66%) than public coverage (35.7%)
▪ Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%),
followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care
(1%)
Coverage Type 2020 2021 Change %
Total 327,521 328,074
Any health plan 299,230 300,887 0.4
Any private plan 217,896 216,366 –0.6
Employment-based 178,737 178,285 –0.2
Direct-purchase 33,869 33,555 –0.1
Marketplace coverage 10,924 11,389 0.1
TRICARE 9,165 8,299 –0.3
Any public plan 112,925 117,095 1.2
Medicare 58,541 60,226 0.5
Medicaid 58,778 61,940 0.9
VA and CHAMPVA 2,967 3,151 0.1
Uninsured 28,291 27,187 –0.4
% of People by Type of Health Insurance Coverage
(2021)
Number of People By Health Insurance Coverage
Illustrative

22
1.8 Budget of Mexico Government for Public Insurance
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31
In Billions Of Dollars
Public
Insarance
$769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
As % Of GDP 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
▪ National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪ Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE
▪ Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE
▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE
▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE
▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE
▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020
▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020
▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020
▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health
spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative

23
1.9 Mergers and Acquisitions
$6.0
$7.7
$10.5
$16.7
$6.8
$11.7
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
82
112 107 107
89
110
1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022
57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020
RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend
Buyer Composition: Strategic Vs Financial (2020)
59%
41% 41%
59% 58%
42%
61%
39%
$0- $25 $25-$50 $50-$100 $100+
Strategic Buyers
Financial Buyers
Buyer Type by Deal Size
($Mn)
Illustrative

24
1.9 Mergers and Acquisitions (continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals In Mexico
Illustrative

2. Market Size and Forecasting

26
XX
XX
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
2.1 Market Size and Forecasts (Excel and Methodology)
Mexico Patient Engagement Solutions Market Forecast, 2022-2030
(in $Bn)
final report
understanding of the overall Patient
Engagement Solutions market in
Mexico, which includes the market size,
current trends and other details related
to the topic
Click on the icon to know the
methodology and assumption
2023 2024 2025 2026 2027 2028 2029 2030
Major Markets Patient
(Mn)
2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
Mexico Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of Mexico Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937
Mexico Market Size (Bn $) 61 74 84 87 91 95 99 106
Illustrative

27
2.2 Snapshot of Patient Engagement Solutions Market Segmentation
▪ In this section you will get an understanding of the segmentations which will cover the Mexico Patient Engagement Solutions Market
▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
By Therapeutic
area
Chronic diseases
Cardiovascular
diseases
Diabetes
Obesity
Women’s health
Others
By Functionality
E- Prescribing
Virtual consultation
Patient Scheduling
Document
management
By Component
Hardware
Software
Services

28
Mexico Patient Engagement Solutions Market Share, By component
(2022)
▪ In component segment Software is a
significant component of the overall
Patient Engagement Solutions market
in Mexico
▪ It has the maximum market share in
Mexico Patient Engagement Solutions
Market with approximately xx%
final report
2.2.1 Market Segmentation: By Component
Illustrative
Hardware
Software
Services

29
Mexico Patient Engagement Solutions Market Share, By
Therapeutic area (2022)
▪ In therapeutic area segment chronic
diseases and cardiovascular diseases
are a significant component of the
overall Patient Engagement Solutions
market in Mexico.
final report
2.2.2 Market Segmentation: By Therapeutic Area
Illustrative
Chronic
diseases
Cardiovascular diseases
Diabetes
Obesity
Women's health
Others

30
Mexico Patient Engagement Solutions Market Share, By
Functionality (2022)
▪ In functionality segment virtual
consultation and patient scheduling are
a significant component of the overall
Patient Engagement Solutions market
in Mexico.
final report
2.2.3 Market Segmentation: By Functionality
Illustrative
E- Prescribing
Virtual
consultation
Patient
scheduling
Document
management

3. Market Dynamics

32
3.1 Market growth drivers
▪ Increase in incidence of cancer cases in Mexico with people suffering
from various cancers requiring patient engagement solutions. Out of all
the cancers breast cancer, lung cancer and prostate cancers are the
most prevalent in Mexico
▪ This is driving the demand for Patient Engagement Solutions such as
patient scheduling and virtual consultation for growth in the Patient
Engagement Solutions market.
▪ Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪ In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪ Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
2010 2022 2030
3.1.1 Growing cancer cases with above 0.25 Mn new cancer cases in Mexico in 2022
Increase in cancer cases in Mexico
Illustrative

33
Increase in patient spending on digital
health technology
▪ Different areas of digital health technologies are developing
rapidly in Mexico like portable devices, mobile health apps,
telemedicine, electronic health records etc.
▪ These technologies are in constant development and
evolution in Mexico
▪ Increase in spending on these facilities by patients acts as a
market growth driver.
Illustrative
2010 2022 2030
3.1 Market growth drivers (continued)
3.1.2 Development of digital health (e-health) technologies and increase in patient spending on these technologies in
Mexico

34
▪ Geriatric population is growing in Mexico at a very high rate.
According to data by United Nations in 2020 the population
aged 60 years and older reached 14.5 million representing
11% of total population.
▪ Due to increase in geriatric population patient engagement
solutions are also increasing in Mexico thus acting as a
market growth driver.
▪ Please be aware that this sample report is intended to
provide you with a brief overview of the kind of information
and analysis that will be presented in the final report
Illustrative
2010 2022 2030
3.1 Market growth drivers (continued)
3.1.3 Growing geriatric population in Mexico at high rate with over 25% population above 60 years by 2050

35
3.2 Market restraints
3.2.1 Privacy and
data security
concerns
▪ Mexico has limited domestic
production capabilities for Patient
engagement programmes
involve exchange of sensitive
health information and therefore
concerns about data security and
privacy arise.
▪ Ensuring robust privacy
measures and complying with
data protection are therefore
necessary.
3.2.2 Low health literacy
and digital literacy levels
in Mexico
▪ Market structure of Patient Low
health literacy and low digital
literacy levels especially among
geriatric population acts as a
market growth restraint.
▪ In this type of situation there is
reluctancy to use digital
solutions.
3.2.3 High development costs
of patient engagement
solutions and lack of skilled
IT professionals in Mexico
▪ High developmental costs of
patient engagement solutions
especially on premise databases
and lack of skilled IT
professionals in Mexico.
▪ Language and cultural diversity
in Mexico also acts as barrier to
development of patient
engagement programmes.
▪ 68 National languages are
recognized in Mexico.
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative

4. Competitive Landscape

37
4.1 Major Market Share
XX
Other
▪ Some of the top companies in Mexico
Patient Engagement Solutions Market
based on revenue and market share
include
interest
Revenue of Major Players in Mexico Patient Engagement Solutions
Market ($ Mn)
Illustrative

38
4.2 Key Company Profile
Key Notes
▪ Here is the list of top 10 companies which
will cover in the final report
▪ Each company will have slides for
o Overview
o Key details
o Offerings
o Name of products
o Recent activities/ Press Coverage
o Distribution and Vendor Partners
o Mergers, Acquisitions and
Collaboration
o Financials
▪ If there are specific companies that you
would like to be included in the report,
please let us know via email
Illustrative
1 Epic Systems
3 Allscripts Healthcare
5 Cerner corporation
7 GetWellNetwork
9 McKesson Corporation
2 AdvancedMD
4 Athenahealth
6 EMMI Solutions
8 Lincor Solutions limited
Medecision Inc.
10

39
4.2.1 EPIC SYSTEMS CORPORATION
Founded in: 1979
HQ: Wisconsin, United states
Type: Private
Website: www.epic.com
▪ Epic Systems corporation develops patient engagement software to
provide patients with tools to be healthier with MyChart which is a
patient portal
▪ It has many centers in the country and operates through online
mode as well
▪ It has global presence in many countries including Mexico
Solutions offered by Epic
➢ Epic Electronic health record
system
➢ Tool for Population health
management
➢ Epic MyChart
➢ Epic Care Ambulatory
Recent Activity / Press Coverage
Epic service corporation joins health information sharing framework called Trusted Exchange Framework and the Common Agreement (TEFCA)
Epic, Microsoft together bring GPT-4 to Electronic health records
Epic system is leader in EHR hospital market share with 83 hospitals joining its network in 2022
Illustrative

40
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem

41
Company Type
Amount /
Shares
Year Key Pointers
Expanding
Strategic
collaboration
-- April 2023
▪ Partnership Collaboration is aimed to develop and integrate
generative AI into healthcare by combining the scale and power
of Azure OpenAI Service with epic’s electronic health record
software
▪ Innovation is focused to increase productivity, enhance patient
care and improve financial integrity of health systems
Latest Deals - Mergers and Acquisitions
Illustrative

42
63.3
70.3 70.9
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Revenues ($Bn), 2020-2030
▪ EPIC systems corporation is a one of the
leading Patient Engagement Solutions
company in Mexico
▪ As of December 31, 2022, the company
had a market share of Xx % in the Patient
Engagement Solutions industry in Mexico
▪ GNC Mexico reported a total revenue of
RM Xx billion for the financial year ended
November 30, 2022, representing a 11%
increase from the previous year
▪ Company's net profit after tax for the same
period was RM Xx Mn, a Xx increase from
the previous year
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative

43
4.2.2 Company 2
Founded in:
HQ:
Type:
Revenue:
Website:
Solutions offered by Company
Drugs Indications
Drugs for Cancer Recent Activity / Press Coverage
Illustrative

44
4.2.2 Company 2 (continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem
Illustrative

45
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals - Mergers and Acquisitions
Illustrative

46
xx xx xx
2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Revenues ($Bn), 2020-2030
▪ Please be aware that this sample report is
report
▪ In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
interest
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
Illustrative

5. Reimbursement Scenario

48
5.1 Reimbursement Regulation in Mexico
The reimbursement scenario in Mexico nutritional supplement market is complex
and can vary depending on the specific treatment, setting of care, and insurance
coverage. Here are some key points to consider:
▪ Public Insurence:
o Medicare is a federal health insurance program for people aged 65 and
older, as well as people with certain disabilities or health conditions
o Medicare covers many cancer treatments, including chemotherapy,
radiation therapy, and some immunotherapies
o However, coverage can be subject to strict guidelines and restrictions,
such as the requirement for prior authorization
o Medicaid is a joint federal-state program that provides health insurance
for people with low incomes
o Medicaid coverage for cancer treatments can vary by state, and may be
subject to limits on the amount and type of treatment covered
▪ Private Insurance:
o Private insurance coverage for cancer treatments can also vary widely
depending on the insurer and the specific policy
o Some policies may have high out-of-pocket costs, such as deductibles
and co-pays, while others may have more comprehensive coverage
Medicare and Medicaid together provide
health insurance coverage for more than
4 in 10 Population
Medicare
17%
Medicaid
and CHIP
21%
Employer-Sponsored
49%
Other Private
3%
Other Public
1%
Uninsured
9%
Health Insurance Coverage, 2022
Illustrative

49
5.1 Reimbursement Regulation in Mexico (continued)
▪ Affordable Care Act:
o Affordable Care Act (ACA) includes provisions to help improve access to cancer treatments by requiring insurers to cover
certain preventive services, including cancer screenings, without co-pays or deductibles
o It also includes protections for people with pre-existing conditions, such as cancer
▪ Reimbursement for New Treatments:
o Reimbursement for new cancer treatments can be a complex and lengthy process, as insurers and government programs
often require evidence of safety and effectiveness before providing coverage
o This can create challenges for companies developing and marketing new treatments
▪ Value-Based Care:
o There is a growing trend towards value-based care, which aims to improve outcomes and lower costs by focusing on the
value of treatments rather than simply the volume of treatments
o Value-based care models can include payment models that tie reimbursement to outcomes or performance metrics
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative

50
5.1 Reimbursement Regulation in Mexico (continued)
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
 Public healthcare coverage is provided by the government and includes programs like
Medicare and Medicaid
 Medicare is a federal program that provides healthcare coverage to individuals who
are 65 years of age or older, as well as certain younger people with disabilities
 Medicaid is a joint federal-state program that provides healthcare coverage to
individuals with low income and limited resources
▪ Shift towards value-based care has been a significant trend in the US healthcare system, with payers and providers increasingly focused on improving patient
outcomes and reducing costs
▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care 38.9%
37.1%
35.6%
32.5%
31.5%
44.0%
46.0%
47.7%
51.0%
51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx xx xx xx xx
2012 2013 2014 2015 2016
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative

51
5.2 Reimbursement Process for Nutritional Supplements
The reimbursement process in the US healthcare system can be complex
and can vary depending on the type of healthcare service, the healthcare
provider, and the insurance coverage. Here are the general steps involved
in the reimbursement process:
▪ Service or Treatment Provided: The healthcare provider performs a
service or treatment for the patient
▪ Billing: The healthcare provider submits a claim to the insurance
company or other payer, requesting reimbursement for the service
provided
▪ Adjudication: The insurance company or other payer reviews the claim
to determine whether it meets the criteria for reimbursement. This can
involve verifying the patient's eligibility, reviewing the treatment
provided, and checking for any potential errors or fraud
▪ Payment: If the claim is approved, the insurance company or other
payer reimburses the healthcare provider for the service provided,
based on the negotiated payment rates or fee schedule
FDA
Private Payers Public Payers
Health Technology Assessment
Payment
Coverage
Coding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 3
2
Illustrative

6. Methodology & Scope

Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

Analysis Methodology
Our Analysis Methodology involves three critical stages:
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Market Data Analysis
& Statistical Model
Interpretation &
Presentation
Secondary
Research
Proprietary
Database
Data
Collection
Primary
Research

Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

2022
2023-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (3 to 5 working days)
with purchase. We will provide you with data
that is currently not a part of our scope as a
part of customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
www.insights10.com
Lifesciences Market
Research Reports you
can trust

www.insights10.com
A large database of over 30,000 syndicated
market research reports in Healthcare Services
and healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Get actionable insights to
take informed business
decisions

Our qualitative, acute, and result-oriented market
research reports provide a comprehensive
understanding of the business scenario and the
latest trends related to the life sciences market
Elevate your business plans
with in-depth market analysis
and industry intelligence
www.insights10.com

Whether you are looking to expand into new
areas, develop new products, or take advantage
of new opportunities we have reports to help you
accelerate and improve your plans by identifying
unique growth prospects.
Gain a competitive edge with
Insights10's customized
healthcare research solutions
www.insights10.com

Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Healthcare Services
(Diseases & Drugs)
Digital
Health
Medical
Devices
across various categories
Market Research Reports

FEATURED REPORTS FREE SAMPLE REPORTS
TRENDING TOPICS

1200+
Reports
Published
Annually
30000+
Life science
Market Research
Reports
22000+
Country
Specific
Reports
2000+
Rare & orphan
Disease
Reports
What makes us different?

Market Overview
Growth Drivers &
Growth Restraints
Market Segmentation
Market Share Factors Driving Future Growth
Reimbursement Scenario
Policy & Regulatory
Landscape
Key Company Profiles
Epidemiology &
Disease type
Competitive Landscape
insights on
which our
reports are
based
1
2
3
4
5
6
10
9
8
7
Table of Contents

Subscription
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database
Service
Primary
Research
Customized
Reports
Market Research
Reports
Our Services

Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis

Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players

What kind of data is presented
in our reports?
Our reports present data, which is:
The report is
prepared using a
proven methodology
and insightful
research
Reliable
The data is prepared
by a team of highly
qualified &
experienced research
analysts & vetted by
our local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything
you would need to
know about the
market including
market size,
competitive analysis
& much more
Comprehensive
You do not have to
be a market expert
to understand what
really is happening
on the market and
how it works
Easy to read

“The business decision-making process is no longer as
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market.
We at Insights10 are building the future of market
research and are committed to providing our clients with
the right intelligence and insights to make business
decisions quickly and efficiently.
Insighs10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working
with some of the best organizations in the world,
generating insights that provides substantial competitive
advantage.”
Dr. Purav Gandhi
Founder & CEO

Purav is a physician and an entrepreneur
with 12+ years of experience in Healthcare
& Life Sciences industry spanning across
strategy, market access, health informatics
and RWE, digital health, analytics and data
science. Purav studied medicine from
Gujarat University and also completed his
MBA from IIM-Kozhikode. Purav started
his career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of experience
in management consulting in the
Life Sciences sector, and has
worked with diverse multinational
firms in the US, India, Middle East
and APAC regions. His primary
area of interest is Customer and
Market Strategy, Market Access,
and Digital Health with special
focus on emerging markets like
Africa, Middle East and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Leadership Team
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research & marketing
professional with a progressive
experience of over 20 years in Life
Sciences, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across diff.
markets (America, Europe, Africa, APAC
and Middle East). Her areas of expertise
include: Indentifying emerging trends in life
sciences industry, Competitor landscape
assessment, Disease opportunity
assessments etc. She is a pro in secondary
and primary research with a deep domain
expertise in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager

Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?

www.insights10.com
Thank you
We truly appreciate your business and
look forward to serving you.

Mexico patient engagement solutions Market Analysis Sample Report

Recommended

Recommended

More Related Content

Similar to Mexico patient engagement solutions Market Analysis Sample Report

Similar to Mexico patient engagement solutions Market Analysis Sample Report (20)

More from Insights10

More from Insights10 (20)

Recently uploaded

Recently uploaded (20)

Mexico patient engagement solutions Market Analysis Sample Report